OpenVSafe by OpenVAERS
Search V-safe

9SC-22686-55143

3 vaccinations 4 coded responses 25 check-ins 4 free-text entries 3 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
975 / OR
Registered
2021-02-17
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-17
    Registered in v-safe
  2. 2021-02-17
    Dose 1 — Pfizer-BioNTech
  3. 2021-02-17
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-02-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-02-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-24
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-03-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-10
    Survey response — day 21, dose 1
    MedDRA: Arthralgia, Eye pain, Headache, Pyrexia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Bilateral eye pain, without redness/discharge, headache, fever, joint pain.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-03-10
    Report sent to call center — day 21, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  14. 2021-03-16
    Dose 2 — Pfizer-BioNTech
  15. 2021-03-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  16. 2021-03-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  17. 2021-03-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-03-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-03-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-03-23
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-03-30
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-06
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-13
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-20
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-29
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-06-15
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-09-16
    Survey response — 6 months, dose 2
    MedDRA: Dyspnoea, Exposure to SARS-CoV-2, Pyrexia — Feeling: Good
    Free text: Week of low grade fevers and couple weeks of shortness of breath following several hours of COVID-19 exposure. Tested negative.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-11-22
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  29. 2022-03-01
  30. 2022-05-23
    Survey response — 6 months, dose 3
    MedDRA: Asthenia, COVID-19, Chest pain, Cough, Fatigue, Malaise, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: Contracted Covid and was sick for approximately 2-3 weeks with fever, cough, fatigue and weakness . Experienced atypical chest pain for 1 week. Resolved now.
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-05-23
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  32. 2022-05-24
  33. 2022-05-24
  34. 2022-11-22
    Survey response — 12 months, dose 3
    MedDRA: COVID-19, Chest pain, No reaction on previous exposure to drug, Pain, Pyrexia — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Week of intermittent sternal chest pain with Covid infection and occasional reoccurrence in the subsequent months. Fever and body aches following last booster which was 4th in the series. First time symptomatic following a vaccination.
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-11-22
    Report sent to call center — 12 months, dose 3
    Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · 1 call case(s)
  36. 2022-11-23
    Call successful
    Participant prefers to complete VAERS report online
  37. 2022-11-23
    Call successful
    Participant prefers to complete VAERS report online
  38. 2022-11-23
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-02-17Pfizer-BioNTech
22021-03-16Pfizer-BioNTech
32021-11-22Pfizer-BioNTech Flu

Call center

3 call center cases

3 successful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 5 — day 21, dose 1

2021-03-10

Symptoms: Bilateral eye pain, without redness/discharge, headache, fever, joint pain.

Release 9 — 6 months, dose 2

2021-09-16

Symptoms: Week of low grade fevers and couple weeks of shortness of breath following several hours of COVID-19 exposure. Tested negative.

Release 11 — 6 months, dose 3

2022-05-23

Symptoms: Contracted Covid and was sick for approximately 2-3 weeks with fever, cough, fatigue and weakness . Experienced atypical chest pain for 1 week. Resolved now.

Release 12 — 12 months, dose 3

2022-11-22

Symptoms: Week of intermittent sternal chest pain with Covid infection and occasional reoccurrence in the subsequent months. Fever and body aches following last booster which was 4th in the series. First time symptomatic following a vaccination.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia ✓ ✓ ✓
SDAsthenia · · ✓
SDChest pain · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDDyspnoea · · ✓
SDExposure to SARS-CoV-2 · · ✓
SDEye pain ✓ ✓ ✓
SDFatigue · · ✓
SDHeadache ✓ ✓ ✓
SDMalaise · · ✓
SDNo reaction on previous exposure to drug · · ✓
SDPain · · ✓
SDPyrexia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release